Research Intern - LNP Formulation - Onsite - Marlborough, MA
Sartorius
About this role
Research Intern position based at Sartorius’ Marlborough, MA site focused on development and integration of emerging technologies for formulation and characterization of lipid nanoparticles (LNPs). The role supports product development from concept to prototype and involves close collaboration with engineers and scientists in a multidisciplinary environment. This is a hands-on, time-limited position starting mid-to-end February 2026 for six months with potential extension up to 12 months.
Skills
Qualifications
About Sartorius
sartorius.comSartorius offers solutions for the biopharmaceutical industry and laboratories, from drug discovery and development to production platforms for biomanufacturing.
Recent company news
Sartorius Introduces Rationally-Designed CHO Host Cell Line
3 days ago
Sartorius Launches New Genetically Engineered CHO Host Cell Line
1 week ago
Sartorius expands sustainable manufacturing network to Germany and Tunisia
1 month ago
Sartorius Stedim Biotech SA: Information on Document Availability
3 weeks ago
Sartorius and MatTek Transaction
Jul 8, 2025
About Sartorius
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Sartorius.
Salary
$0 – $60k
per year
More jobs at Sartorius
Similar Jobs
Senior/Research Associate, Drug Product Development
NewLimit
Associate Scientist, LNP Formulations
Flagship Pioneering, Inc.
Principal Scientist, Analytical Development
Flagship Pioneering, Inc.
Research Assistant/Technician 2
The University of British Columbia
Senior Scientist, LNP Sciences
Beam Therapeutics
Research Associate, LNP Formulations
Flagship Pioneering, Inc.